Factors modifying the aggregation of atrophin-1 acting in cis and in trans
Ten polyQ (polyglutamine) diseases constitute a group of hereditary, neurodegenerative, lethal disorders, characterized by neuronal loss and motor and cognitive impairments. The only common molecular feature of polyQ disease-associated proteins is the homopolymeric polyglutamine repeat. The pathological expansion of polyQ tract invariably leads to protein misfolding and aggregation, resulting in formation of the fibrillar intraneuronal deposits (aggregates) of the disease protein. The polyQ-related cellular toxicity is currently attributed to early, small, soluble aggregate species (oligomers), whereas end-stage, fibrillar, insoluble aggregates are considered to be benign. In the complex cellular environment aggregation and toxicity of mutant polyQ proteins can be affected by both the sequences of the corresponding disease protein (factors acting in cis) and the cellular environment (factors acting in trans). Additionally, the nucleus has been suggested to be the primary site of toxicity in the polyQ-based neurodegeneration. In this study, the dynamics and structure of nuclear and cytoplasmic inclusions were examined to determine the intrinsic and extrinsic factors influencing the cellular aggregation of atrophin-1, a protein implicated in the pathology of dentatorubral-pallidoluysian atrophy (DRPLA), a polyQ-based disease with complex clinical features. Dynamic imaging, combined with biochemical and biophysical approaches revealed a large heterogeneity in the dynamics of atrophin-1 within the nuclear inclusions compared with the compact and immobile cytoplasmic aggregates. At least two types of inclusions of polyQ-expanded atrophin-1 with different mobility of the molecular species and ability to exchange with the surrounding monomer pool coexist in the nucleus of the model cell system, neuroblastoma N2a cells. Furthermore, our novel cross-seeding approach which allows for monitoring of the architecture of the aggregate core directly in the cell revealed an evolution of the aggregate core of the polyQ-expanded ATN1 from one composed of the sequences flanking the polyQ domain at early aggregation phases to one dominated by the polyQ stretch in the later aggregation phase. Intriguingly, these changes in the aggregate core architecture of nuclear and cytoplasmic inclusions mirrored the changes in the protein dynamics and physico-chemical properties of the aggregates in the aggregation time course. 2D-gel analyses followed by MALDI-TOF MS (matrix-assisted laser desorption/ionization time of flight mass spectrometry) were used to detect alterations in the interaction partners of the pathological ATN1 variant compared to the non-pathological ATN1. Based on these results, we propose that the observed complexity in the dynamics of the nuclear inclusions provides a molecular explanation for the enhanced cellular toxicity of the nuclear aggregates in polyQ-based neurodegeneration.
polyQ, Atrophin-1, Proteinmissfaltung, Proteinaggregation, misfolding, aggregation
Networked Digital Library of Theses and Dissertations